146 related articles for article (PubMed ID: 12479368)
1. Enhanced de novo ceramide generation through activation of serine palmitoyltransferase by the P-glycoprotein antagonist SDZ PSC 833 in breast cancer cells.
Wang H; Giuliano AE; Cabot MC
Mol Cancer Ther; 2002 Jul; 1(9):719-26. PubMed ID: 12479368
[TBL] [Abstract][Full Text] [Related]
2. N-(4-hydroxyphenyl)retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase.
Wang H; Maurer BJ; Reynolds CP; Cabot MC
Cancer Res; 2001 Jul; 61(13):5102-5. PubMed ID: 11431347
[TBL] [Abstract][Full Text] [Related]
3. The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular ceramide formation.
Cabot MC; Han TY; Giuliano AE
FEBS Lett; 1998 Jul; 431(2):185-8. PubMed ID: 9708899
[TBL] [Abstract][Full Text] [Related]
4. SDZ PSC 833 the drug resistance modulator activates cellular ceramide formation by a pathway independent of P-glycoprotein.
Goulding CW; Giuliano AE; Cabot MC
Cancer Lett; 2000 Feb; 149(1-2):143-51. PubMed ID: 10737718
[TBL] [Abstract][Full Text] [Related]
5. Ceramide signaling in fenretinide-induced endothelial cell apoptosis.
Erdreich-Epstein A; Tran LB; Bowman NN; Wang H; Cabot MC; Durden DL; Vlckova J; Reynolds CP; Stins MF; Groshen S; Millard M
J Biol Chem; 2002 Dec; 277(51):49531-7. PubMed ID: 12388538
[TBL] [Abstract][Full Text] [Related]
6. Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis.
Perry DK; Carton J; Shah AK; Meredith F; Uhlinger DJ; Hannun YA
J Biol Chem; 2000 Mar; 275(12):9078-84. PubMed ID: 10722759
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells.
Lucci A; Han TY; Liu YY; Giuliano AE; Cabot MC
Cancer; 1999 Jul; 86(2):300-11. PubMed ID: 10421266
[TBL] [Abstract][Full Text] [Related]
8. SDZ PSC 833, the cyclosporine A analogue and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drug-resistant cancer cells.
Cabot MC; Giuliano AE; Han TY; Liu YY
Cancer Res; 1999 Feb; 59(4):880-5. PubMed ID: 10029079
[TBL] [Abstract][Full Text] [Related]
9. Increasing intracellular ceramide: an approach that enhances the cytotoxic response in prostate cancer cells.
Wang H; Charles AG; Frankel AJ; Cabot MC
Urology; 2003 May; 61(5):1047-52. PubMed ID: 12736045
[TBL] [Abstract][Full Text] [Related]
10. Taxol-induced ceramide generation and apoptosis in human breast cancer cells.
Charles AG; Han TY; Liu YY; Hansen N; Giuliano AE; Cabot MC
Cancer Chemother Pharmacol; 2001 May; 47(5):444-50. PubMed ID: 11391861
[TBL] [Abstract][Full Text] [Related]
11. Selective susceptibility of transformed T lymphocytes to induction of apoptosis by PSC 833, an inhibitor of P-glycoprotein.
Azare J; Pankova-Kholmyansky I; Salnikow K; Cohen D; Flescher E
Oncol Res; 2001; 12(8):315-23. PubMed ID: 11589302
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling.
Scarlatti F; Sala G; Somenzi G; Signorelli P; Sacchi N; Ghidoni R
FASEB J; 2003 Dec; 17(15):2339-41. PubMed ID: 14563682
[TBL] [Abstract][Full Text] [Related]
13. De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis.
Gómez del Pulgar T; Velasco G; Sánchez C; Haro A; Guzmán M
Biochem J; 2002 Apr; 363(Pt 1):183-8. PubMed ID: 11903061
[TBL] [Abstract][Full Text] [Related]
14. Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells.
Gouazé-Andersson V; Yu JY; Kreitenberg AJ; Bielawska A; Giuliano AE; Cabot MC
Biochim Biophys Acta; 2007 Dec; 1771(12):1407-17. PubMed ID: 18035065
[TBL] [Abstract][Full Text] [Related]
15. De novo N-palmitoylsphingosine synthesis is the major biochemical mechanism of ceramide accumulation following p53 up-regulation.
Panjarian S; Kozhaya L; Arayssi S; Yehia M; Bielawski J; Bielawska A; Usta J; Hannun YA; Obeid LM; Dbaibo GS
Prostaglandins Other Lipid Mediat; 2008 Jun; 86(1-4):41-8. PubMed ID: 18400537
[TBL] [Abstract][Full Text] [Related]
16. Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle.
Dobrzyn A; Dobrzyn P; Lee SH; Miyazaki M; Cohen P; Asilmaz E; Hardie DG; Friedman JM; Ntambi JM
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E599-607. PubMed ID: 15562249
[TBL] [Abstract][Full Text] [Related]
17. Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression.
Shimabukuro M; Higa M; Zhou YT; Wang MY; Newgard CB; Unger RH
J Biol Chem; 1998 Dec; 273(49):32487-90. PubMed ID: 9829981
[TBL] [Abstract][Full Text] [Related]
18. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
Beketic-Oreskovic L; Durán GE; Chen KG; Dumontet C; Sikic BI
J Natl Cancer Inst; 1995 Nov; 87(21):1593-602. PubMed ID: 7563202
[TBL] [Abstract][Full Text] [Related]
19. Palmitoyl-ceramide accumulation with necrotic cell death in A549 cells, followed by a steep increase in sphinganine content.
Yamane M
Biochim Open; 2015; 1():11-27. PubMed ID: 29632826
[TBL] [Abstract][Full Text] [Related]
20. De novo ceramide accumulation due to inhibition of its conversion to complex sphingolipids in apoptotic photosensitized cells.
Dolgachev V; Farooqui MS; Kulaeva OI; Tainsky MA; Nagy B; Hanada K; Separovic D
J Biol Chem; 2004 May; 279(22):23238-49. PubMed ID: 15020599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
